Haemonetics (HAE) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $119.50 -0.24%
Revenue Growth %: +5.6%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Revenue Growth %: +5.6%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $228.1 million versus the consensus estimate of $219.42 million.
GUIDANCE:
Haemonetics sees FY2018 EPS of $1.55-$1.65, versus the consensus of $1.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
- Why Beijing could block the SpaceX-Tesla merger
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
